Cargando…
Restoring Treatment Response in Colorectal Cancer Cells by Targeting MACC1-Dependent ABCB1 Expression in Combination Therapy
Treatment failure of solid cancers, represented by the development of drug resistance in the primary tumor or later outgrowth of drug resistant metastases, is the major cause of death for cancer patients. It represents an urgent clinical need for predictive biomarkers which indicate the success or f...
Autores principales: | Dahlmann, Mathias, Werner, Rebecca, Kortüm, Benedikt, Kobelt, Dennis, Walther, Wolfgang, Stein, Ulrike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190815/ https://www.ncbi.nlm.nih.gov/pubmed/32391276 http://dx.doi.org/10.3389/fonc.2020.00599 |
Ejemplares similares
-
Combinatorial treatment with statins and niclosamide prevents CRC dissemination by unhinging the MACC1-β-catenin-S100A4 axis of metastasis
por: Kortüm, Benedikt, et al.
Publicado: (2022) -
Calcium-binding protein S100P is a new target gene of MACC1, drives colorectal cancer metastasis and serves as a prognostic biomarker
por: Schmid, Felicitas, et al.
Publicado: (2022) -
MACC1-Induced Collective Migration Is Promoted by Proliferation Rather Than Single Cell Biomechanics
por: Hohmann, Tim, et al.
Publicado: (2022) -
MACC1 driven alterations in cellular biomechanics facilitate cell motility in glioblastoma
por: Hohmann, Tim, et al.
Publicado: (2020) -
The newly identified MEK1 tyrosine phosphorylation target MACC1 is druggable by approved MEK1 inhibitors to restrict colorectal cancer metastasis
por: Kobelt, Dennis, et al.
Publicado: (2021)